Influencing factors for the functional cure of chronic hepatitis B and related mechanism
10.3969/j.issn.1001-5256.2022.08.004
- VernacularTitle:影响慢性乙型肝炎功能性治愈的因素及其机制
- Author:
Yifei GUO
1
;
Jiming ZHANG
2
Author Information
1. National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China
2. National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China;Shanghai Institute of Major Infectious Diseases and Biosafety, Shanghai 200032, China
- Publication Type:Discussions by Experts
- Keywords:
Hepatitis B, Chronic;
Hepatitis B Surface Antigens;
Hepatitis B e Antigens;
Antiviral Agents
- From:
Journal of Clinical Hepatology
2022;38(8):1721-1725
- CountryChina
- Language:Chinese
-
Abstract:
Functional cure of chronic hepatitis B (CHB), defined as negative hepatitis B surface antigen (HBsAg) with or without the presence of hepatitis B surface antibody (anti-HBs), is considered the optimal endpoint for CHB treatment at present. Studies have shown that HBsAg clearance can reduce the risk of HBV complications such as liver cirrhosis and hepatocellular carcinoma. However, HBsAg clearance rate remains at a relatively low level, which may be associated with the immune tolerance state caused by HBV infection. HBsAg clearance and/or the presence of anti-HBs indicate the partial recovery of HBV-specific immunity. This article discusses the influencing factors for the functional cure of CHB and the underlying mechanisms.
